2024 Approvals

FDA Approves NEXLETOL for High Cholesterol Management on March 22, 2024

FDA Approves NEXLETOL for High Cholesterol Management on March 22, 2024

What is NEXLETOL prescribed for?   Nexletol is approved to help decrease LDL cholesterol in adults with heart disease or heterozygous familial hypercholesterolemia (HeFH). What is the name of the drug and what does it do? NEXLETOL, pronounced NEX-le-tol, (generic name: bempedoic acid) is a prescription medicine originally used to help reduce the risk of...

How FDA-Approved Doxycycline, Approved on June 6, 2024, is Helping with Rising STI Cases

How FDA-Approved Doxycycline, Approved on June 6, 2024, is Helping with Rising STI Cases

What is Doxycycline prescribed for?   Doxycycline is an antibiotic that's used to treat infections in adults  including but not limited to: chest and dental infections. skin infections and conditions like rosacea sexually transmitted infections (STIs) What is the name of the drug and what does it do?  This drug is called Doxycycline...

New Blood Test for Colon Cancer Recommended for Approval: May 24, 2024

New Blood Test for Colon Cancer Recommended for Approval: May 24, 2024

What is it prescribed for?   The Guardant Health Shield test is a blood test that screens for colorectal cancer (CRC) in people who are 45 and older and at average risk of the disease.  The test looks for DNA fragments from tumor cells and precancerous growths in blood samples collected with a Guardant Blood Collection Kit. What is the name of the drug and what...

New Liquid Medication Approved for ADHD Treatment: May 30, 2024

New Liquid Medication Approved for ADHD Treatment: May 30, 2024

What is Onyda XR prescribed for?   ONYDA XR (Clonidine Hydrochloride) is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy (using a single drug for a disease) and as adjunctive therapy (an additional treatment used alongside primary therapy to enhance effectiveness) to central nervous system (CNS) stimulant...

FDA Approves First CRISPR Gene Therapy in January 2024 to Treat Beta-Thalassemia

FDA Approves First CRISPR Gene Therapy in January 2024 to Treat Beta-Thalassemia

What is Casgevy prescribed for?   Casgevy is prescribed to treat people aged 12 years and older with sickle cell disease (SCD) who have frequent vaso-occlusive crises or VOCs. What is the name of the drug and what does it do?  Casgevy pronounced cass-JEH-vee, generic name:(exagamglogene autotemcel) is an innovative treatment specifically designed for...